D

Dyne Therapeutics

Develops muscle-disease therapies using FORCE platform

Director, Oligonucleotide Manufacturing

Bioprocess & BiomanufacturingConfirmed live in the last 24 hours
Full-timeWaltham, MA, USA$200k - $240k

About the Job

Requirements

  • An advanced degree in Chemistry, Biochemistry, Chemical Engineering, Pharmaceutical Sciences, or a related discipline is required.
  • At least 10 years of progressive experience in oligonucleotide manufacturing and CMC, including hands-on experience with oligonucleotide payloads, oligonucleotide-based therapeutics, and conjugates.
  • Experience translating program or CMC strategy into functional manufacturing plans, priorities, budgets, timelines, and risk-mitigation actions.
  • Significant experience selecting, governing, and influencing CDMOs, with accountability for cGMP performance, quality, compliance, cost, and supply outcomes.
  • Strong business and financial acumen, including experience with forecasting, external manufacturing spend, resource planning, and investment tradeoffs.
  • Demonstrated ability to lead complex cross-functional work, reconcile competing priorities, and influence decisions without direct authority.
  • Experience establishing governance, operating standards, and scalable processes, and building capability through coaching, knowledge transfer, or team development.
  • Strong knowledge of pharmaceutical and biotechnology industry trends, product development and life cycle management, global regulatory requirements, and clinical-stage manufacturing.
  • Strong judgment, facilitation, negotiation, and problem-solving skills, including the ability to make and communicate recommendations on complex technical and business matters.
  • Excellent verbal, written, and presentation skills, including the ability to communicate effectively with senior leaders, cross-functional teams, regulators, contractors, and external partners.
  • Ability to operate independently, lead in a matrixed environment, and adapt priorities as business and program needs evolve.

Responsibilities

  • Translate CMC and program strategy into integrated oligonucleotide manufacturing plans, priorities, budgets, resource requirements, timelines, and risk-mitigation actions for late-stage clinical and commercial supply.
  • Lead oligonucleotide payload manufacturing from late-stage clinical development through commercial launch, setting and delivering against functional objectives, operational targets, and key milestones.
  • Select, qualify, and govern external CDMOs, establishing performance expectations, operating standards, escalation pathways, and accountability for quality, compliance, cost, service, and delivery.
  • Ensure uninterrupted clinical and commercial supply through long-range capacity planning, demand and supply alignment, scenario planning, and proactive mitigation of continuity risks.
  • Provide financial stewardship for external manufacturing activities by developing forecasts, managing spend, evaluating investment options, and recommending cost, capacity, and sourcing tradeoffs.
  • Lead technology transfer, scale-up, process validation, process improvements, and timely resolution of complex manufacturing issues across external partners.
  • Review and approve cGMP documentation, including technology transfer, process and analytical development and validation reports, qualification protocols and reports, validation master batch records, and campaign summary reports.
  • Prepare and review CMC sections for global regulatory submissions, including INDs, IMPDs, and BLAs, and support responses to health authority questions and inspections.
  • Lead cross-functional decision-making with Research, Regulatory, Quality, Clinical, Finance, and other stakeholders to define compliant, scientifically sound, and executable CMC strategies.
  • Advise senior leadership on manufacturing strategy, partner performance, supply risk, capacity, investment needs, and technical or business tradeoffs.
  • Build scalable internal CMC and manufacturing capabilities through resource planning, knowledge transfer, development of standards and processes, and coaching of employees and cross-functional partners.
  • Evaluate and implement emerging technologies and external capabilities that improve product quality, process performance, scalability, and cost effectiveness.
  • Prepare and deliver technical documentation, governance updates, publications, and presentations for internal and external audiences.

Desired Qualifications

  • Commercial launch experience.

About the Company

Dyne Therapeutics

Develops muscle-disease therapies using FORCE platform

Dyne Therapeutics develops therapies for serious muscle diseases using its FORCE™ platform, which helps deliver oligonucleotide medicines to muscle tissue. Through a portfolio of experimental therapies, the company advances them in clinical trials (ACHIEVE and DELIVER) with the aim of treating rare muscle diseases. The product works by enhancing targeted delivery of oligonucleotides to muscle, enabling existing genetic medicines to reach affected tissues more effectively. Dyne differentiates itself by its proprietary FORCE™ technology and its focus on rare muscle diseases, positioning itself for growth as trials progress toward potential commercialization. The company’s goal is to bring effective treatments to patients and families affected by serious muscle diseases, expanding options as its therapies advance through development and, potentially, regulatory approval.

Company size
201-500
Company stage
IPO
Headquarters
Waltham, MA
Founded
2017

Recently Posted Jobs

Explore more opportunities at Dyne Therapeutics

See more jobs